Vertex Announces $50 Million Commitment to Health Equity With Three Initial Gran… – Press Release

 – Vertex grant to JDRF supports efforts to improve clinical trial diversity in type 1 diabetes –

The Vertex Foundation grant supports the Mass General Comprehensive Sickle Cell Disease Treatment Center –

Additional Vertex Foundation grant to Year Up to support health care workforce training –

Vertex Pharmaceuticals Incorporated VRTX today announced that Vertex and the Vertex Foundation, a nonprofit charitable foundation, have committed $50 million over five years to clinical trial diversity, access to quality care, and education of our health care workforce. The donations are an extension of Vertex’s long-standing commitment to inclusion, diversity and equity and the existing work of the Vertex Foundation to promote these values through education, innovation and various health programs.

“We’re delighted to be working with Year Up, JDRF and the Massachusetts General Hospital, along with a number of other extraordinary organizations to advance our collective goal of having a more equitable society as a whole and a more equitable health care system in particular,” said Reshma Kewalramani, M.D., Chief Executive Officer and President at Vertex. “In conjunction with our announcement today of the expansion of our cell and genetic therapies footprint, this $50 million commitment reflects our ongoing commitment to close the gaps in health care research, access, quality and patient outcomes for underrepresented communities.”

Clinical trial diversity

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is broadening the understanding and awareness of T1D and getting more people involved in clinical trials, screening, monitoring and research. Vertex is supporting JDRF’s efforts to improve clinical trial diversity which will help champion advanced care through clinical trial education, awareness and recruitment efforts, including diverse representation.

“JDRF is dedicated to supporting every individual diagnosed with…